Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $81,979.59 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Robert L. Scavo sold 5,313 shares of the stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $15.43, for a total transaction of $81,979.59. Following the completion of the sale, the insider now directly owns 668,106 shares of the company's stock, valued at $10,308,875.58. The trade was a 0.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Alignment Healthcare Stock Up 1.9 %

ALHC traded up $0.30 during trading on Monday, hitting $16.09. The company had a trading volume of 2,691,822 shares, compared to its average volume of 1,400,843. The company has a market cap of $3.09 billion, a PE ratio of -20.90 and a beta of 1.49. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $16.30. The business has a 50-day moving average of $14.38 and a 200-day moving average of $12.46.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently modified their holdings of the stock. R Squared Ltd bought a new stake in Alignment Healthcare in the fourth quarter valued at about $55,000. RiverPark Advisors LLC bought a new position in Alignment Healthcare during the 4th quarter worth approximately $106,000. Tower Research Capital LLC TRC grew its position in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after acquiring an additional 6,286 shares in the last quarter. Ballentine Partners LLC bought a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Alignment Healthcare during the 3rd quarter valued at approximately $131,000. Institutional investors own 86.19% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several analysts recently issued reports on the company. Piper Sandler increased their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. Stifel Nicolaus increased their target price on Alignment Healthcare from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Friday, February 28th. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Stephens restated an "overweight" rating and issued a $17.00 price target on shares of Alignment Healthcare in a report on Monday, February 24th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research note on Thursday, March 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Alignment Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.